Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor. Li L, Yin J, Zhang L, Liu W, et al. Br J Cancer 2025 Aug 26. doi: 10.1038/s41416-025-03145.

Read + Share

Amedeo Smart

Independent Medical Education

Li L, Yin J, Zhang L, Liu W, et al. Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor. Br J Cancer 2025 Aug 26. doi: 10.1038/s41416-025-03145.
PMID: 40858831